Analyses – Non-invasive

Analyses – Non-invasive

NACE test
Nace test

Do you want a prenatal test without pain, without risk to the health of your baby?

You just give your blood sample for analysis and get results within 5 days?

Non-invasive prenatal test NACE reveals chromosomal abnormalities in such a simple and safe way.
During pregnancy, the baby’s DNA circulates in the mother’s blood. This latest technology analyses maternal blood and gives us the ability to isolate the baby’s genetic material and determine its genetic health after 10 weeks.

SAFE it does not bear any risk for the baby or the mother
NON-INVASIVE NACE test requires only one tube of maternal blood
RELIABLE this method analyses chromosomal disorders with high precision, it detects Down’s syndrome with precision of 99.9%
FAST avoid waiting for long time for the results, you get them in 4 to 5 days

The most prestigious European genetic laboratory Igenomix from Spain chose Genesis to be the first in Southeast Europe to introduce these latest genetic tests and methods.

Make an appointment with a gynaecologist at hospital Genesis by calling 021 549 777
After consultation with the gynaecologist, you will be tested if this this proves necessary.
Then we will take a blood sample from your veins, and it is stored in special plastic tubes and sent to Spain to Igenomix laboratory for the necessary analysis.
Your gynaecologist will receives the results by e-mail within 5 days and sends them to you in a way you have previously agreed (orally, by telephone or e-mail).

IMPORTANT NOTICE!
If the result is positive, it is necessary to do the amniocentesis.
In this case, hospital Genesis will do this test free of charge!

 

ERA TEST
Henetika era test

It determines genetic endometrial receptivity, that is, the personalised window of implantation of each woman. The test showed that 27% of patients are not receptive according to the protocols which include implantation of the embryo on the third or the fifth day after taking oocytes and fertilization.

According to the clinical analysis, ERA increases success of IVF for 25% for patients of all ages who have had one or more unsuccessful IFV procedures and have problems with implantation of a fertilized egg in the uterus.
If you do a combination of ERA and PGS testing, the success rate is 80%.

The most renowned genetic laboratory “Igenomix” from Spain has chosen hospital “Genesis” from Novi Sad to be the first in Southeast Europe to introduce this most advanced non-invasive prenatal genetic test.
The test is carried out by doing a blood analysis, and the results are obtained within about 2 to 3 weeks.

 

CGT
Genetika cgt

This test estimates the genetic compatibility before planned pregnancy in order to determine whether the couple carries the risk of developing any genetic anomalies. If both partners are carriers of mutations in the same gene, the test will help to prevent the birth of children with genetic defects on the same gene.
CGT test helps to detect 15.000 mutations and 600 genetic disorders, such as cystic fibrosis, muscular dystrophy, Gaucher’s disease, anaemia, and other phenomena.
If the result is positive for both partners, it is very likely that they will have a sick child. They might have healthy children if they do Preimplantation Genetic Diagnosis – PGD. There is also the possibility of natural conception with proper prenatal diagnosis.
The most renowned genetic laboratory “Igenomix” from Spain has chosen hospital “Genesis” from Novi Sad to be the first in Southeast Europe to introduce this most advanced non-invasive prenatal genetic test.
30 to 40 days after taking the sample are necessary for the analysis and the preparation of the results.

 

SAT
Genetika sat test

It is a diagnostic test that should determine whether there are genetic causes of male infertility. It enables the analysis of chromosomes 13, 18, 21, X and XY because they are usually responsible for spontaneous abortions, and result in the transmission of chromosomal abnormalities to the embryo.
This test identifies men with low success in reproduction and provides useful information for personalized genetic counselling of couples before starting IVF treatment. They are generally advised to undergo PGS test, which allows the selection of embryos with normal chromosomes for the fertilization of eggs cells and the increases success in getting pregnant, and reduces the risk of miscarriages.
The most renowned genetic laboratory “Igenomix” from Spain has chosen hospital “Genesis” from Novi Sad to be the first in Southeast Europe to introduce this most advanced non-invasive prenatal genetic test.
The test results can be expected two weeks from giving the blood sample.

 

PGS
Genetikia pgs test

This test allows us to, before the implantation, analyse all 24 chromosomes, do genetic screening for aneuploidy (chromosomal abnormalities) and identify a healthy embryo to be used in IVF treatment.
Genetic abnormalities are a common cause of early spontaneous disorders in the first trimester of pregnancy. These methods help us to prevent such losses.
PGS method focuses on the chromosomes that carry information about the disorders and allows us to choose to transfer only those embryos who have normal chromosomes.
By using PGS screening test the successfulness of IVF treatment may be doubled!
150% in older women
132% in case of problems with implantation
71% in case of repeated miscarriages
64% when the cause of the issue is the male infertility

What are the benefits of PGS test?
Most of abnormal embryos cannot be examined under a microscope and thus they cannot be differentiated from healthy embryos. Therefore, we cannot use only the appearance of the embryo as a criterion for the detection of chromosomal abnormalities.

Who is exposed to an increased risk when it comes to the development of abnormalities in the number of chromosomes?

  • Women in their thirties and older are at higher risk than younger women.
  • Women with repeated miscarriages, or repeated absence of the implantation in the IVF treatment.
  • Women with a history of previous pregnancies with chromosomal abnormalities
  • Men with abnormal results of semen analysis.

Main advantages of PGS include: increasing implantation rates, reducing the spontaneous abortions rate and increasing the chances that the couple will give birth to a healthy child.

Embryo biopsy is done with a laser and sent to genetic testing to the most influential genetic laboratory “Igenomix” from Spain, which has chosen hospital “Genesis” from Novi Sad to be the first in Southeast Europe to introduce the most advanced non-invasive prenatal genetic test.

PGD
Genetika pgd test

PGD is Preimplantation Genetic test used to analyse disorders at the level of genes. This is a highly-reliable test that can be performed during the IVF treatment. In this way, embryos at risk to develop a serious genetic disorder are tested.

PGD ​​is carried out after embryo biopsy, and the sample is sent for genetic testing to the most influential genetic laboratory “Igenomix” from Spain, which has chosen hospital “Genesis” from Novi Sad to be the first in Southeast Europe to introduce the most advanced non-invasive genetic test.
Testing differentiates healthy embryos from embryos that are carriers of genetic disorders.
This test enables families with an increased risk of genetic disorders o have healthy children.

The test results can be expected up to two weeks after taking the sample.

 

BRCA ½
Genetika brca test

Genetic screening tests BRCA 1 and BRCA 2 are carried out by a technique of sequencing which aims to locate mutations in both genes. They are responsible for 5 to 10% of all breast cancer, and for 10 to 15% of all ovarian cancers.

If a woman has inherited BRCA 1 and BRCA 2 gene mutation from her parents, she is facing an increased risk of developing breast cancer and ovarian cancer. A positive test result has important consequences on the health of family members, and even on future generations, because the person who inherits harmful mutations in these genes, can transfer them to his/her sons and daughters. Every child in this case, has a 50% chance of inheriting the mutation from their parents, if the parent is the mutation carrier.

The testing is done by analysing blood samples in the usual way, and the results are ready in a month.